CXCR4/CXCL12阻塞疗法;TNBC治疗的新视野
Abdulrahman Qais Khaleel1, Farag M A Altalbawy2, Majid S Jabir3
1Department of Medical Instruments Engineering, Al-Maarif University College, Al Anbar, 31001, Iraq. abdulrahman.qais@uoa.edu.iq.
Medical oncology (Northwood, London, England)
|April 11, 2025
概括
三阴性乳腺癌 (TNBC) 缺乏向疗法. CXCR4/CXCL12轴在TNBC进展和治疗耐药性方面发挥着关键作用,提供了潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种缺乏向治疗的侵袭性亚型,占乳腺癌病例的15-20%.
- 瘤微环境 (TME),包括非恶性细胞,细胞外基质和可溶性因子,如细胞因子,显著影响TNBC的发展和治疗耐药性.
- 化学基因,如CXCL12/CXCR4轴,越来越多地被认为在TNBC病理生理学中的关键作用.
研究的目的:
- 审查CXCR4/CXCL12轴在三阴性乳腺癌中的多方面的作用.
- 阐明这一轴在TNBC发育,转移,血管新生和获得的治疗耐药性的参与.
- 总结当前关于针对TNBC潜在治疗干预措施的CXCR4/CXCL12轴的文献.
主要方法:
- 文献综述综合了临床前和临床研究的发现.
- 对TNBC中CXCR4/CXCL12信号的基础分子机制的分析.
- 收集针对CXCR4/CXCL12轴的治疗策略的数据.
主要成果:
- CXCR4/CXCL12轴与促进TNBC细胞增殖和存活有关.
- 这个轴促进瘤血管新生和形成前转移性微环境.
- CXCR4/CXCL12信号传递有助于抵抗各种癌症疗法.
结论:
- CXCR4/CXCL12轴是TNBC进展和治疗反应的关键调节器.
- 针对CXCR4/CXCL12轴是开发新型TNBC治疗的有希望的战略.
- 对这一轴的进一步研究可能会发现新的治疗点和组合策略,以改善患者的治疗结果.
关键词:
在CXCL12中,CXCL12是最重要的.CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4C药物耐药性 药物耐药性 药物耐药性增长的增长 增长的增长转移 转移 转移 转移美国TNBC电视台更多相关视频
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
13.6K
07:36Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
6.3K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)